The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved]
Background Individuals with first-episode psychosis (FEP) face an increased risk of physical comorbidities, notably cardiovascular diseases, metabolic disorders, respiratory disorders, and certain types of cancer. Previous reviews report pooled physical health prevalence from chronic psychosis and F...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2025-01-01
|
| Series: | HRB Open Research |
| Subjects: | |
| Online Access: | https://hrbopenresearch.org/articles/6-75/v2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590321151639552 |
|---|---|
| author | Michael Norton Brian O'Donoghue Mary Clarke Karen O'Connor Jennifer Murphy Anna Zierotin |
| author_facet | Michael Norton Brian O'Donoghue Mary Clarke Karen O'Connor Jennifer Murphy Anna Zierotin |
| author_sort | Michael Norton |
| collection | DOAJ |
| description | Background Individuals with first-episode psychosis (FEP) face an increased risk of physical comorbidities, notably cardiovascular diseases, metabolic disorders, respiratory disorders, and certain types of cancer. Previous reviews report pooled physical health prevalence from chronic psychosis and FEP groups. By contrast, this review will focus on antipsychotic-naïve FEP cohorts and incorporate data from observational longitudinal studies and antipsychotic intervention studies to understand the progression of physical health comorbidities from the onset to later stages of psychosis. This review aims to examine the short-, medium-, and long-term period prevalence of these comorbidities in FEP and variations related to demographic factors. Methods Using the PRISMA and MOOSE guidelines, Medline, Embase, PsycINFO, and CINAHL+, as well as Clinical Trials gov.uk, OpenGrey, WHO International Clinical Trials Registry Platform, Current Controlled Trials, United States National Institute of Health Trials Registry, and the Irish Health Repository, will be searched from inception. Longitudinal studies and antipsychotic intervention studies monitoring health outcomes in antipsychotic naïve FEP individuals will be eligible for inclusion. Two reviewers will independently screen titles, abstracts, and full-text articles. Risk of bias will be assessed using the Joanna Briggs Institute Critical Appraisal Checklist. A meta-analysis of the short-, medium-, and long-term prevalence of cardiovascular, metabolic, cancer, and respiratory outcomes and a narrative synthesis will be conducted. Where feasible, a meta-regression on the impact of demographic variables will be conducted. Potential limitations include the risk of diagnostic heterogeneity across studies and possible underreporting of certain comorbidities. Conclusions This systematic review will clarify the progression of physical health comorbidities in FEP, informing early intervention strategies and policies. Subsequent findings will be submitted to a leading journal, supplemented by a recovery education module and a lay summary for wider dissemination. Registration The study was registered in PROSPERO, the International Prospective Register of Systematic Reviews (CRD42023431072; 17/06/2023). |
| format | Article |
| id | doaj-art-44b215805b5e483d9ddbb2e936e3a94e |
| institution | Kabale University |
| issn | 2515-4826 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | HRB Open Research |
| spelling | doaj-art-44b215805b5e483d9ddbb2e936e3a94e2025-01-24T01:00:00ZengF1000 Research LtdHRB Open Research2515-48262025-01-01615441The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved]Michael Norton0https://orcid.org/0000-0002-7420-9339Brian O'Donoghue1Mary Clarke2Karen O'Connor3Jennifer Murphy4https://orcid.org/0000-0002-2480-7656Anna Zierotin5https://orcid.org/0009-0002-6200-6726Recovery and Engagement Lead, Office of Mental Health Engagement and Recovery, Health Service Executive, County Dublin, IrelandDepartment of Psychiatry, University College Dublin, Dublin, Leinster, IrelandDepartment of Psychiatry, University College Dublin, Dublin, Leinster, IrelandRISE Early Intervention in Psychosis Service, South Lee Mental Health Service, Cork, IrelandDepartment of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Leinster, IrelandDepartment of Psychiatry, University College Dublin, Dublin, Leinster, IrelandBackground Individuals with first-episode psychosis (FEP) face an increased risk of physical comorbidities, notably cardiovascular diseases, metabolic disorders, respiratory disorders, and certain types of cancer. Previous reviews report pooled physical health prevalence from chronic psychosis and FEP groups. By contrast, this review will focus on antipsychotic-naïve FEP cohorts and incorporate data from observational longitudinal studies and antipsychotic intervention studies to understand the progression of physical health comorbidities from the onset to later stages of psychosis. This review aims to examine the short-, medium-, and long-term period prevalence of these comorbidities in FEP and variations related to demographic factors. Methods Using the PRISMA and MOOSE guidelines, Medline, Embase, PsycINFO, and CINAHL+, as well as Clinical Trials gov.uk, OpenGrey, WHO International Clinical Trials Registry Platform, Current Controlled Trials, United States National Institute of Health Trials Registry, and the Irish Health Repository, will be searched from inception. Longitudinal studies and antipsychotic intervention studies monitoring health outcomes in antipsychotic naïve FEP individuals will be eligible for inclusion. Two reviewers will independently screen titles, abstracts, and full-text articles. Risk of bias will be assessed using the Joanna Briggs Institute Critical Appraisal Checklist. A meta-analysis of the short-, medium-, and long-term prevalence of cardiovascular, metabolic, cancer, and respiratory outcomes and a narrative synthesis will be conducted. Where feasible, a meta-regression on the impact of demographic variables will be conducted. Potential limitations include the risk of diagnostic heterogeneity across studies and possible underreporting of certain comorbidities. Conclusions This systematic review will clarify the progression of physical health comorbidities in FEP, informing early intervention strategies and policies. Subsequent findings will be submitted to a leading journal, supplemented by a recovery education module and a lay summary for wider dissemination. Registration The study was registered in PROSPERO, the International Prospective Register of Systematic Reviews (CRD42023431072; 17/06/2023).https://hrbopenresearch.org/articles/6-75/v2First-episode Psychosis Physical Health Comorbidities Metabolic Health Cardiovascular Health Respiratory Health Cancereng |
| spellingShingle | Michael Norton Brian O'Donoghue Mary Clarke Karen O'Connor Jennifer Murphy Anna Zierotin The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] HRB Open Research First-episode Psychosis Physical Health Comorbidities Metabolic Health Cardiovascular Health Respiratory Health Cancer eng |
| title | The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] |
| title_full | The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] |
| title_fullStr | The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] |
| title_full_unstemmed | The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] |
| title_short | The short-, medium-, and long-term prevalence of physical health comorbidities in first-episode psychosis: a systematic review and meta-analysis protocol [version 2; peer review: 3 approved] |
| title_sort | short medium and long term prevalence of physical health comorbidities in first episode psychosis a systematic review and meta analysis protocol version 2 peer review 3 approved |
| topic | First-episode Psychosis Physical Health Comorbidities Metabolic Health Cardiovascular Health Respiratory Health Cancer eng |
| url | https://hrbopenresearch.org/articles/6-75/v2 |
| work_keys_str_mv | AT michaelnorton theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT brianodonoghue theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT maryclarke theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT karenoconnor theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT jennifermurphy theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT annazierotin theshortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT michaelnorton shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT brianodonoghue shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT maryclarke shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT karenoconnor shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT jennifermurphy shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved AT annazierotin shortmediumandlongtermprevalenceofphysicalhealthcomorbiditiesinfirstepisodepsychosisasystematicreviewandmetaanalysisprotocolversion2peerreview3approved |